Alcon Inc. (ALC) exhibits 41.0% gross margins and 9.9% return on invested capital within Health Care (Ophthalmic Goods), balanced against a 21.0x enterprise multiple and 6.9% implied options volatility.
Sustained 41.0% gross profitability converts into 13.9% operating margin and 9.9% ROIC, outpacing sector cost of capital.
ROIC: 9.9% // GM: 41.0%YoY revenue trajectory of -3.3% paired with 2.21% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -3.3% // FCF YLD: 2.21%Altman Z-Score of 3.74 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.74 // F-SCORE: 7/9Trading at 32.8x trailing P/E (30.5x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 32.8x // EV/EBITDA: 21.0xOptions market prices a ±6.9% implied move with a 0.64 put/call ratio around $70.00 max pain.
IMPL MOVE: ±6.9% // P/C: 0.64Elevated industry capital intensity and customer concentration in Ophthalmic Goods require continuous execution to defend 10.9% net margins.
NET MARGIN: 10.9% // D/E: 0.39x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ALC & activate live FRED threshold breach alerts.